GuidanceMHRA
Advertising and Promotion following agreement of the Windsor Framework
This guidance is designed to provide information on the implementation of changes to advertising and promotion of medicines authorised in the UK from 1 January 2025.
First published: Nov 7, 2024Last updated: Mar 11, 2025Changes: 2
Latest change: Updated to remove footnote: '1. Subject to the UK providing written guarantees to the European Commission as provided for in Article 8 of EU Regulation 2023/1182 and following the entry into force and application procedure provided for in Article 14'
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.